Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

ArticleOpen access20263citation· Semantic Scholar

Prevalence of hyperemesis gravidarum and its associated electrolyte and hematologic disturbances in pregnant women

Frontiers in Medicine · vol. 13 · 1703120-1703120

Background and objective: Hyperemesis gravidarum (HG) is a condition that develops early in pregnancy, before 16 weeks of gestation, and is characterized by severe nausea and/or vomiting, inability to tolerate food and/or beverages, and substantial impairment of daily activities. Hyperemesis gravidarum can have obvious maternal and fetal consequences. This study aimed to assess the prevalence of HG, investigate its associated electrolyte and hematologic disturbances, and identify risk factors among pregnant women in Aljouf, Saudi Arabia. Methods: A retrospective observational case-control study was conducted using 200 medical records selected from a total of 9,090 records of pregnant women at the Maternity and Children Hospital in Aljouf, covering the period from November 2020 to November 2023. Results: The prevalence of hyperemesis gravidarum was 1.1% among the studied pregnant women. Patients diagnosed with hyperemesis gravidarum showed significantly lower body weight and BMI than controls. Nearly 48% of HG cases occurred in women aged 30-39 years, while 52% were in the first trimester. Furthermore, 36% of the affected women were primigravida, and 11% were pregnant with twins. Hypotension was observed in 35% of HG cases. Hyponatremia occurred in 29% of patients, hypokalemia in 21%, and hypochloremia in 24%. Hematological disturbances included increased Hb levels in 11% of cases, increased hematocrit in 12%, leukocytosis in 19%, and neutrophilia in 17% of the patients. Conclusion: Hypotension, electrolyte imbalance, and hematological disturbances are the primary consequences of HG. First-trimester pregnancy and low gestational age are the most important risk factors for HG. Strategies by healthcare centers and further research are needed to enhance the treatment, management, and prevention methods of HG.

hyperemesis gravidarumprevalenceelectrolyte imbalancehyponatremia
ArticleOpen access20263citation· Semantic Scholar

Barriers and enablers affecting female participation in physical activity

Frontiers in Global Women s Health · vol. 6 · 1707792-1707792

Background: Physical activity offers numerous health benefits and helps prevent various diseases, making it an essential component of a healthy lifestyle. Objective: This study aims to examine the barriers and enablers that affect female participation in physical activity. Methods: This was a cross-sectional quantitative study. The study questionnaire was adopted from a previous study. The survey was conducted online and completed by 668 Saudi women from across the country. Results: The study findings regarding low physical activity levels among Saudi women are concerning, as 72.2% of participants were classified as sedentary or physically inactive. The study revealed that age, employment status, and income were significant factors affecting engagement of women in physical activity. Moreover, barriers such as expensive gym memberships, a lack of women-only clubs, a lack of enjoyment in sports, and prolonged use of the same exercise devices prevented Saudi women from participating in physical activities. However, women reported exercising to boost their self-satisfaction and self-confidence, thereby promoting overall health. Conclusion: Saudi women exhibit a low level of physical activity. Barriers such as expensive gym memberships, a lack of women-only clubs, a lack of enjoyment in sports, prolonged use of the same exercise devices, and motivations related to self-satisfaction and self-confidence prevent Saudi women from practicing physical activities. Health system policymakers need to take action to increase physical activity levels and address these barriers.

physical activitybarriers to exercisesedentary behaviorSaudi women
ArticleClosed20263citation· Semantic Scholar

Integrative in silico-in vivo modeling identifies apigenin modulation of TGF-β1/SMAD2 in methotrexate-induced cardiotoxicity

Toxicology Mechanisms and Methods · vol. 36 (3) · 412-431

Methotrexate (METX) is a widely used chemotherapeutic and immunosuppressive agent, frequently employed as a first-line treatment for various malignancies and autoimmune disorders. Despite its clinical efficacy, METX is known to induce cardiotoxicity primarily through mechanisms involving oxidative stress, inflammation, and apoptosis. Apigenin (API), a natural dietary flavonoid, exhibits potent antioxidant and anti-inflammatory properties. The current study evaluated the protective effects of API against METX-induced cardiotoxicity in mice, focusing on the modulation of transforming growth factor-β (TGF-β)/(SMAD2) signaling. Molecular docking was done to investigate the possible inhibition of TGF-β by API and bioinformatic tools were utilized to investigate the correlation between the target proteins. Male Swiss albino mice were randomly distributed to four groups: Group I: a saline group, Group II: a METX control group (20 mg/kg, per week), Group III: METX + API (40 mg/kg, per day) and Group IV: METX + API (80 mg/kg, per day, via oral gavage); the study continued for three weeks. Our findings suggest that API administration significantly mitigated METX cardiotoxicity and serum CK-MB, likely through attenuation of the inflammatory cytokines (NF-κB, IL-1β, TNF-α, and IL-6) and suppression of cardiac TGF-β/SMAD2 signaling. The congruence between bioinformatics and experimental validation findings strongly highlighted API as a promising therapeutic candidate for alleviating METX cardiotoxicity. While the current data reveals key underlying molecular mechanisms for API′s cardioprotective effect, further comprehensive studies across diverse cardiotoxicity models are essential to fully elucidate cardioprotective effect of API.

apigeninTGF-β/Smad2 signalingflavonoidscardioprotection
ReviewOpen access20263citation· Semantic Scholar

Early Surgery or Conservative Management for Adhesive Small Bowel Obstruction: A Comprehensive Systematic Review of Short- and Long-Term Outcomes

Cureus · vol. 18 (1) · e101184-e101184

Adhesive small bowel obstruction (aSBO) is a common cause of emergency surgical admission, and the optimal initial management between early surgery and conservative non-operative management (NOM) remains debated, particularly regarding recurrence and short-term safety. This systematic review aimed to evaluate short- and long-term outcomes of early operative management compared with conservative treatment for aSBO in adult and paediatric populations. A systematic search of MEDLINE, Embase, Scopus, and Cochrane CENTRAL was conducted from inception to 2025 in accordance with PRISMA guidelines. Nine studies were included. In stable adults, NOM was generally safe with comparable short-term complication and mortality rates to early surgery; however, prolonged delays following NOM failure were associated with increased morbidity and bowel resection. Long-term outcomes consistently favoured early operative management, demonstrating a 40-60% relative reduction in recurrence. Water-soluble contrast protocols improved diagnostic accuracy and NOM success, while specific radiological findings predicted failure. In paediatric patients, NOM was effective in many cases, but infants under one year of age had a higher likelihood of requiring surgery, and delays beyond 48 hours increased bowel resection rates. Overall, NOM is safe for selected patients, but early surgery offers superior long-term recurrence outcomes.

adhesive small bowel obstructionearly surgical interventionconservative treatmentrecurrence
ArticleOpen access20263citation· Semantic Scholar

Development and Validation of a Robust RP‐HPLC Method for Quantifying Dasatinib in Self‐Microemulsifying Drug Delivery Systems

International Journal of Analytical Chemistry · vol. 2026 (1) · 4376722-4376722

Dasatinib, a therapy for chronic myeloid leukemia, suffers from poor bioavailability. Self‐microemulsifying drug delivery systems (SMEDDSs) are used to improve its dissolution. This study aimed to develop and validate a novel reverse‐phase high‐performance liquid chromatography (RP‐HPLC) method for quantifying dasatinib in SMEDDS formulations. The RP‐HPLC method utilized a mobile phase of methanol and 0.1% trifluoroacetic acid (55:45, v/v) and identified a peak wavelength for dasatinib at 324 nm. SMEDDS formulations comprised Capryol 90, Transcutol HP, and Tween 40. The method was validated according to ICH guidelines, demonstrating excellent linearity ( R 2 = 0.9993), accuracy (recovery between 98% and 101%), and precision (relative standard deviation of 0.73%). It also showed stability and reliability with limits of detection and quantification of 0.17 and 0.50 µg/mL, respectively. This RP‐HPLC method meets all validation criteria and provides a robust, cost‐effective tool for analyzing dasatinib in SMEDDS formulations.

dasatinibself-microemulsifying drug delivery systemRP-HPLC method developmentmethod validation
ArticleOpen (repository)20262citation· Semantic Scholar

Adolescent health across Asia Pacific, 2000–23: a systematic analysis for the Global Burden of Disease Study 2023

The Lancet Child & Adolescent Health · vol. 10 (10) · 731-754

BACKGROUND: The Asia Pacific region is home to more than half of the world's 1·93 billion adolescents (aged 10-24 years). Addressing adolescent health in this region is of global importance, but to date a systematic analysis of key contributors to disease in adolescents has not been done, which is a barrier to responsive action. This systematic analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 aims to provide a comprehensive assessment of adolescent health across the Asia Pacific region, at both the subregional and national levels, encompassing burden of disease, mortality, and prevalence of adolescent risk factors. METHODS: As part of GBD 2023, we obtained estimates for cause-specific mortality, disability-adjusted life-years (DALYs), and risk factor prevalence by sex for adolescents aged 10-24 years and 5-year age groups (10-14 years, 15-19 years, and 20-24 years) across 44 countries and territories (hereafter referred to collectively as Asia Pacific), grouped by seven UN subregions, from 2000 to 2023. We extracted GBD 2023 population counts and estimates of number and rate (per 100 000 population) for mortality and disease burden (DALYs). Risk prevalence estimates were obtained directly from the Institute for Health Metrics and Evaluation, and binge drinking estimates were sourced from WHO. Estimates are reported with 95% uncertainty intervals (UIs) where possible. UIs were estimated by running 250 draws of the posterior distribution, ordering the draws, and selecting the 2·5th and 97·5th percentiles for each metric. FINDINGS: In 2023, in adolescents across Asia Pacific, there were 637 496 deaths and a total disease burden of 115·8 million DALYs, representing 34·1% of global adolescent deaths and 40·6% of the global adolescent burden of disease. Non-communicable diseases (NCDs; particularly mental disorders) were the leading causes of disease burden and mortality (64·8% of DALYs and 43·9% of deaths). Unintentional and transport injuries were also leading causes of death (14·7% of deaths due to transport injury and 13·3% of deaths due to unintentional injury) and leading causes of disease burden particularly among males in south-eastern Asia. In Melanesia, Micronesia, and some parts of south-eastern Asia (Cambodia, Indonesia, Laos, the Philippines, and Timor-Leste), respiratory infections and tuberculosis remained important contributors. Southern Asia had the largest reduction (1·5% per year) in all-cause DALYs over the study period, and Australia and New Zealand (0·2% per year) had the smallest, with females in Australia and New Zealand showing a slight increase contrary to regional trends. Eastern Asia had the largest reduction (2·8% per year) in all-cause mortality rate and Melanesia (0·8% per year) the smallest. Risk factors generally had between-subregion and within-subregion variation; however, some regional trends stood out, with overweight and obesity increasing in all countries across the region, and binge drinking increasing in more countries than not. In 2023, prevalence of smoking in males exceeded that in females in every country, from 40% difference in Timor-Leste to less than 1% difference in Australia. Anaemia prevalence is decreasing in all countries, but female prevalence was higher and reducing at a slower rate than in males. Bullying prevalence was slightly higher in Polynesia, Micronesia, and Melanesia combined, Australia and New Zealand, and eastern Asia compared with southern and south-eastern Asian subregions. INTERPRETATION: Several patterns were consistent across the region: the dominance of mental disorders and NCDs, the universal rise in overweight and obesity (particularly high in Oceanic countries but increasing rapidly in south and south-eastern Asia), and persistent sex-specific challenges across subregions: unintentional injuries and smoking in males, and anaemia in females. Actions to tackle shared risk factors (while accounting for context-specific local health profiles, workforce deficits, cultural factors, and health system capacity) should not be forgone due to local variation. Future research could focus on subnational variation, intersecting inequalities, and multi-sectoral interventions targeting shared risk factors. Priority actions should include regional investment in adolescent mental health services and obesity prevention, targeted injury reduction strategies for high-risk populations, and sex-specific approaches to smoking cessation and anaemia reduction, delivered through local health systems with the capacity and cultural responsiveness to meet local needs. FUNDING: Gates Foundation and Australian Government.

adolescent healthdisease burdenadolescent mortalitydisability-adjusted life years
ArticleOpen access20262citation· Semantic Scholar

High-intensity versus low-intensity laser acupuncture in chronic, non-specific low back pain: a double-blinded, randomized controlled trial

Frontiers in Medicine · vol. 13 · 1857622-1857622

Background: Chronic nonspecific low back pain (CNSLBP) is a musculoskeletal condition characterized by persistent discomfort, weak trunk muscles, exhaustion, and disability. Objectives: The purpose of this study is to compare the effects of high-intensity laser acupuncture (HILA) and low-intensity laser acupuncture (LILA), combined with exercise, on strength of trunk extensors, fatigue, level of pain, range of motion (ROM) of lumbar flexion, and disability in patients with CNSLBP. Materials and methods: 60 participants with CNSLBP were divided into three groups in this randomized, double-blind, sham-controlled trial: the high-intensity laser (HILA) group, who received HILA over 15 acupuncture points along with exercises; the low-intensity laser (LILA) group, who received LILA over the same points plus exercises; and the sham group, who received sham laser in addition to exercises. The interventions were received three times/week for four consecutive weeks. The strength of trunk extensors, fatigue, pain, lumbar flexion ROM, and disability were measured at baseline, after 4 weeks, and at a 1-month follow-up. The assessment tools used included isokinetic dynamometry, the visual analogue scale (VAS), the modified Schober test (MST), and the Oswestry Disability Index (ODI). Results: < 0.05). However, fatigue and disability did not differ between the two active laser groups. All groups showed minor changes between the post-treatment and follow-up periods. Conclusion: Patients with CNSLBP may have a short-term benefit from HILA and LILA combined with exercise rather than from exercise alone in terms of trunk extensor strength and fatigue, pain, lumbar flexion ROM, and disability. However, both laser treatments showed comparable effects on fatigue and disability; HILA appears to be more effective than LILA in improving trunk extensor strength and relieving pain. To define the ideal treatment parameters and to evaluate long-term effects, further research is required. Clinical Trial Registration: https://clinicaltrials.gov/, identifier [NCT06280846].

chronic non-specific low back painlaser acupunctureexercise therapytrunk extensor strength
ArticleClosed20262citation· Semantic Scholar

Anatomical Fidelity in Text‐to‐Image Generative AI : A Comparative Qualitative and Quantitative Evaluation

Clinical Anatomy

Traditional anatomical resources like cadaveric dissection and professional atlases are the gold standard, but face constraints in cost and accessibility. The rapid integration of generative artificial intelligence (AI) in medical education offers new possibilities for custom anatomical illustration. Text-to-image AI generators provide an inexpensive and swift alternative for medical illustration. However, the anatomical fidelity and educational reliability of these models remain insufficiently validated. This study aimed to evaluate the accuracy of four prominent AI image generators in producing anatomically correct illustrations of the human heart, kidney, and brain. Four AI platforms-Copilot, Microsoft Designer, Gemini, and Freepik-were prompted to generate high-resolution, textbook-style illustrations of the heart (sternocostal view), kidney (coronal cross-section), and brain (lateral view). A total of 12 selected images were evaluated by a radiologist and two anatomists utilizing a structured 5-point Likert scale across five domains: textural realism, topological validity, morphometric accuracy, perspective and depth perception, and educational utility. Significant variability in performance was observed across platforms. Gemini consistently demonstrated superior performance, achieving perfect intraclass correlation coefficients (ICCs) and the highest ratings on complex topological tasks, including the representation of coronary vasculature and cortical sulci/gyri. Copilot showed high spatial accuracy in renal hilum organization. While all platforms showed high reliability and accuracy across broad morphological shapes (aortic arch, cerebral poles), accuracy declined sharply as anatomical complexity increased. AI-generated anatomical illustrations currently vary from medically indistinguishable to biologically impossible. While Gemini and Copilot show promise for supplemental educational use, the high frequency of hallucinated anatomical details in other platforms poses a risk for medical misinformation. The study underscores the necessity for expert supervision and for developing AI models trained on curated, peer-reviewed medical datasets.

text-to-image generative AIanatomical fidelitymedical illustrationAI hallucination
ArticleOpen access20262citation· Semantic Scholar

Novel anti-virulence strategy against Helicobacter pylori using Lactiplantibacillus plantarum cell-free supernatants

Frontiers in Microbiology · vol. 17 · 1881796-1881796

Helicobacter pylori is one of the most prevalent pathogenic microorganisms worldwide. The treatment of H. pylori infections is challenging due to the increasing antibiotic resistance. Therefore, alternative therapies are crucial for addressing these issues. This study aimed to investigate alternative approaches to combat H. pylori infection using lactic acid bacteria. Nineteen LAB isolates exhibited strong tolerance to simulated gastric acid and bile salts, as well as notable auto-aggregation and co-aggregation capabilities. Among them, isolates L20, L22, and L40 showed superior performance. Their neutralized cell-free supernatants (n-CFSs) significantly inhibited H. pylori urease production by 69, 66, and 67%, respectively, and reduced biofilm formation by 88, 82, and 80%, respectively. Molecular identification revealed that isolates L20 and L40 belonged to Lactiplantibacillus plantarum , while L22 was identified as Limosilactobacillus fermentum . Furthermore, the n-CFS of L. plantarum L20 markedly downregulated the expression of H. pylori virulence genes, including vacA , cagA , ureA , and babA, with fold reductions of 79, 68, 90, and 96%, respectively. In vivo , treatment with L. plantarum L20 n-CFS resulted in 1.28 log reduction in H. pylori colonization ( p < 0.001). Proteomic analysis further identified metabolically active proteins associated with catalytic and secondary metabolite pathways, supporting their mechanistic role in anti- H. pylori activity. These findings highlight the potential of LAB-derived n-CFS, particularly L. plantarum L20, as a promising antivirulent strategy against H. pylori infections.

Helicobacter pylorianti-virulence strategiesLactobacillus plantarumcell-free supernatant
ReviewClosed20262citation· Semantic Scholar

USFDA‐Approved Small Molecules in the Year 2025: Medicinal Chemistry Strategies and Trends

Archiv der Pharmazie · vol. 359 (6) · e70272-e70272

Small-molecule-based therapeutics play a vital role in drug discovery. These molecules are preferred owing to their oral bioavailability, ease of tuning the physicochemical properties, and broad target accessibility. In this review article, we have explored the small molecules approved by the US Food and Drug Administration (USFDA) in 2025. Through the analysis, we found 44 drug approvals, out of which 30 candidates were approved as new molecular entities (NMEs), while the remaining 14 were approved in the category of biologics, including 10 approved as biosimilars. Considering the therapeutic area distribution of 30 NMEs, 28 drugs are approved as monotherapy, with 10 drugs as anticancer agents, 4 drugs for genetic disorders, 2 drugs each for the conditions of immunological, respiratory, ophthalmic, and endocrine disorders, along with the treatment of cardiac and infectious diseases. The structural diversity analysis revealed that 29 approved drugs were aromatic (azaheterocycles) in nature, and 13 drugs possess at least one stereogenic center. Considering the elemental diversity, the near-universal presence of nitrogen in the form of amines, amides, and as a heteroatom, followed by the oxygen atom. Additionally, the prevalence of 3- or 4-membered carbocyclic or heterocyclic rings was found in five approved drugs. For metabolism, most drugs rely on CYP3A-mediated metabolism, primarily through CYP3A4, CYP2D6, and CYP2C8. Collectively, the analysis and compilation of the drugs presented are expected to provide practical insights and offer guidance to medicinal chemists, biologists, and scientists associated with current drug-discovery paradigms, making continuous strides for future medicinal chemistry innovations and evolutions.

FDA-approved drugsnew chemical entitiessmall molecule drugsdrug discovery